Results 51 to 60 of about 5,563 (197)
Aim The benzoxaborole derivative DNDI‐6148 is an antiparasitic agent with activity against multiple Leishmania protozoan species, including L. infantum and L. donovani, which cause visceral leishmaniasis. We investigated the safety, tolerability and pharmacokinetics of single oral doses of DNDI‐6148 in a randomized, parallel‐group, placebo‐controlled ...
Jean‐Yves Gillon +12 more
wiley +1 more source
Presentation of AIDS with Disseminated Cutaneous and Visceral Leishmaniasis in Iran
Leishmaniasis is an infectious disease in form of visceral (VL), cutaneous (CL), and mucocutaneous (MCL) leishmaniasis. Immunocompromised patients have increased risk of Leishmania infection, especially in endemic areas for visceral leishmaniasis, where
Mohammadali Davarpanah +2 more
doaj +1 more source
Leishmania enriettii in guinea pig (Cavia porcellus) in southern Brazil [PDF]
: Leishmaniasis is a parasitic disease with a worldwide distribution, transmitted to animals and humans through the blood meal of sand flies, caused by protozoa of the genus Leishmania.
Michelli L. de Souza +6 more
doaj +1 more source
Localised Leishmaniasis of Oral Mucosa: Report of an Unusual Clinicopathological Entity
The term leishmaniasis comprises of a group of diseases caused by different species of a protozoan called Leishmania. There are three main clinical forms of leishmaniasis: visceral leishmaniasis, cutaneous leishmaniasis, and mucocutaneous leishmaniasis ...
Deepak Passi +3 more
doaj +1 more source
Introduction: The pathogenesis of cutaneous and mucosal leishmaniasis is associated with different immune responses. Vitamin D may modulate the immune system. Here we evaluate the association of vitamin D levels with the severity of the clinical forms of
Lorena Pinheiro Figueiredo +4 more
doaj +1 more source
In a series of substituted 1‐[5‐(5‐nitrofuran‐2‐yl)‐1,3,4‐thiadiazol‐2‐yl]piperidine‐4‐carboxamides evaluated for in vitro antileishmanial and antitrypanosomal activity, compound 18 emerged as the most promising derivative, showing submicromolar anti‐parasitic effects targeting diverse Leishmania and Trypanosoma species and acceptable selectivity ...
Alireza Mousavi +17 more
wiley +1 more source
Mucocutaneous leishmaniasis: A clinicopathologic classification
Leishmaniasis, a chronic parasitic disease transmitted by Phlebotomus sandflies, affects millions of patients. Mucocutaneous leishmaniasis caused by Leishmania brasiliensis is endemic in much of South America.Our purpose was to develop a system for staging mucocutaneous leishmaniasis on the basis of clinical, histopathologic, epidemiologic, and ...
O P, Sangueza +3 more
openaire +2 more sources
Cutaneous Leishmaniasis in High‐Altitude: A Case Report From Nepal
ABSTRACT Leishmaniasis is a parasitic infection caused by Leishmania and spread by the bite of a sandfly, most commonly Phlebotomus. Among the three subtypes of Leishmaniasis, cutaneous leishmaniasis is the most common form. Visceral Leishmaniasis is common in Nepal whereas few cases of cutaneous leishmaniasis have been reported in migrant Nepalese ...
Eliz Aryal +5 more
wiley +1 more source
Mucocutaneous leishmaniasis in Australia: A case report
Rationale: Australia is the only inhabited continent, which is not endemic to leishmaniasis. There are some published articles reporting cutaneous leishmaniasis in travellers, immigrants and refugees.
Anjali Abraham +3 more
doaj +1 more source
Schematic representation depicting the influence of phosphine ligand identity on the biological and physicochemical characteristics of Pt(II) complexes: PTA promotes antileishmanial activity, PPh2(Php–COOH) strengthens antiviral activity, and TCEP enhances fluorescence.
Antonio A. de Oliveira‐Neto +12 more
wiley +1 more source

